A renowned researcher estimates that 22,000 patients could have been saved if the Food and Drug Administration removed the heart surgery drug Trasylol two years ago. Scott Pelley reports.
CBSNews.com

Related news articles:

• Bayer Temporarily Suspends Global Trasylol® Marketing
• Bayer Issues Additional Guidance to Physicians on Trasylol®
• FDA Advisory Committees Recommend Continued US Marketing Authorization for Trasylol